These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31988837)

  • 21. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
    Shoaib M; Kamal MA; Rizvi SMD
    Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug repurposing in psoriasis, performed by reversal of disease-associated gene expression profiles.
    Ahmed F; Ho SG; Samantasinghar A; Memon FH; Rahim CSA; Soomro AM; Pratibha ; Sunildutt N; Kim KH; Choi KH
    Comput Struct Biotechnol J; 2022; 20():6097-6107. PubMed ID: 36420161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interpretation of risk loci from genome-wide association studies of Alzheimer's disease.
    Andrews SJ; Fulton-Howard B; Goate A
    Lancet Neurol; 2020 Apr; 19(4):326-335. PubMed ID: 31986256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genome-wide pathway analysis of a genome-wide association study on psoriasis and Behcet's disease.
    Lee YH; Choi SJ; Ji JD; Song GG
    Mol Biol Rep; 2012 May; 39(5):5953-9. PubMed ID: 22201026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathway-based analysis using reduced gene subsets in genome-wide association studies.
    Zhao J; Gupta S; Seielstad M; Liu J; Thalamuthu A
    BMC Bioinformatics; 2011 Jan; 12():17. PubMed ID: 21226955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Functional Pipeline of Genome-Wide Association Data Leads to Midostaurin as a Repurposed Drug for Alzheimer's Disease.
    Esteban-Martos A; Brokate-Llanos AM; Real LM; Melgar-Locatelli S; de Rojas I; Castro-Zavala A; Bravo MJ; Mañas-Padilla MDC; García-González P; Ruiz-Galdon M; Pacheco-Sánchez B; Polvillo R; Rodriguez de Fonseca F; González I; Castilla-Ortega E; Muñoz MJ; Rivera P; Reyes-Engel A; Ruiz A; Royo JL
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Afach S; Doney L; Dressler C; Hua C; Mazaud C; Phan C; Hughes C; Riddle D; Naldi L; Garcia-Doval I; Le Cleach L
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011535. PubMed ID: 31917873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A High-Throughput Screening Approach To Repurpose FDA-Approved Drugs for Bactericidal Applications against Staphylococcus aureus Small-Colony Variants.
    Trombetta RP; Dunman PM; Schwarz EM; Kates SL; Awad HA
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30381352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular mechanisms underlying variations in lung function: a systems genetics analysis.
    Obeidat M; Hao K; Bossé Y; Nickle DC; Nie Y; Postma DS; Laviolette M; Sandford AJ; Daley DD; Hogg JC; Elliott WM; Fishbane N; Timens W; Hysi PG; Kaprio J; Wilson JF; Hui J; Rawal R; Schulz H; Stubbe B; Hayward C; Polasek O; Järvelin MR; Zhao JH; Jarvis D; Kähönen M; Franceschini N; North KE; Loth DW; Brusselle GG; Smith AV; Gudnason V; Bartz TM; Wilk JB; O'Connor GT; Cassano PA; Tang W; Wain LV; Soler Artigas M; Gharib SA; Strachan DP; Sin DD; Tobin MD; London SJ; Hall IP; Paré PD
    Lancet Respir Med; 2015 Oct; 3(10):782-95. PubMed ID: 26404118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integration of genomic variants and bioinformatic-based approach to drive drug repurposing for multiple sclerosis.
    Afief AR; Irham LM; Adikusuma W; Perwitasari DA; Brahmadhi A; Chong R
    Biochem Biophys Rep; 2022 Dec; 32():101337. PubMed ID: 36105612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs.
    Cordell HJ; Fryett JJ; Ueno K; Darlay R; Aiba Y; Hitomi Y; Kawashima M; Nishida N; Khor SS; Gervais O; Kawai Y; Nagasaki M; Tokunaga K; Tang R; Shi Y; Li Z; Juran BD; Atkinson EJ; Gerussi A; Carbone M; Asselta R; Cheung A; de Andrade M; Baras A; Horowitz J; Ferreira MAR; Sun D; Jones DE; Flack S; Spicer A; Mulcahy VL; Byan J; Han Y; Sandford RN; Lazaridis KN; Amos CI; Hirschfield GM; Seldin MF; Invernizzi P; Siminovitch KA; Ma X; Nakamura M; Mells GF; ; ; ; ; ; ;
    J Hepatol; 2021 Sep; 75(3):572-581. PubMed ID: 34033851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Druggable Genes for Asthma by Integrated Genomic Network Analysis.
    Adikusuma W; Chou WH; Lin MR; Ting J; Irham LM; Perwitasari DA; Chang WP; Chang WC
    Biomedicines; 2022 Jan; 10(1):. PubMed ID: 35052792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug Repurposing of Selected Antibiotics: An Emerging Approach in Cancer Drug Discovery.
    Bano N; Parveen S; Saeed M; Siddiqui S; Abohassan M; Mir SS
    ACS Omega; 2024 Jun; 9(25):26762-26779. PubMed ID: 38947816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computational drug repurposing for inflammatory bowel disease using genetic information.
    Grenier L; Hu P
    Comput Struct Biotechnol J; 2019; 17():127-135. PubMed ID: 30728920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets.
    Dand N; Stuart PE; Bowes J; Ellinghaus D; Nititham J; Saklatvala JR; Teder-Laving M; Thomas LF; Traks T; Uebe S; Assmann G; Baudry D; Behrens F; Billi AC; Brown MA; Burkhardt H; Capon F; Chung R; Curtis CJ; Duckworth M; Ellinghaus E; FitzGerald O; Gerdes S; Griffiths CEM; Gulliver S; Helliwell P; Ho P; Hoffmann P; Holmen OL; Huang ZM; Hveem K; Jadon D; Köhm M; Kraus C; Lamacchia C; Lee SH; Ma F; Mahil SK; McHugh N; McManus R; Modalsli EH; Nissen MJ; Nöthen M; Oji V; Oksenberg JR; Patrick MT; Perez-White BE; Ramming A; Rech J; Rosen C; Sarkar MK; Schett G; Schmidt B; Tejasvi T; Traupe H; Voorhees JJ; Wacker EM; Warren RB; Wasikowski R; Weidinger S; Wen X; Zhang Z; ; ; Barton A; Chandran V; Esko T; Foerster J; Franke A; Gladman DD; Gudjonsson JE; Gulliver W; Hüffmeier U; Kingo K; Kõks S; Liao W; Løset M; Mägi R; Nair RP; Rahman P; Reis A; Smith CH; Di Meglio P; Barker JN; Tsoi LC; Simpson MA; Elder JT
    medRxiv; 2023 Oct; ():. PubMed ID: 37873414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multi-omics integration reveals molecular networks and regulators of psoriasis.
    Zhao Y; Jhamb D; Shu L; Arneson D; Rajpal DK; Yang X
    BMC Syst Biol; 2019 Jan; 13(1):8. PubMed ID: 30642337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combinational Drug Repurposing from Genetic Networks Applied to Alzheimer's Disease.
    Nabirotchkin S; Bouaziz J; Glibert F; Mandel J; Foucquier J; Hajj R; Callizot N; Cholet N; Guedj M; Cohen D
    J Alzheimers Dis; 2022; 88(4):1585-1603. PubMed ID: 35811522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Translating GWAS Findings to Inform Drug Repositioning Strategies for COVID-19 Treatment.
    Tsai MJ; Jeong S; Yu F; Chen TF; Li PH; Juan HF; Huang JH; Hsu YH
    Res Sq; 2023 Oct; ():. PubMed ID: 37886583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring anti-malarial potential of FDA approved drugs: an in silico approach.
    Ramakrishnan G; Chandra N; Srinivasan N
    Malar J; 2017 Jul; 16(1):290. PubMed ID: 28720135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Turning genome-wide association study findings into opportunities for drug repositioning.
    Lau A; So HC
    Comput Struct Biotechnol J; 2020; 18():1639-1650. PubMed ID: 32670504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.